Patient Guide: A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 52 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06422507
Status: ACTIVE_NOT_RECRUITING
Condition: Diabetic Macular Edema
Phase: PHASE3

Find a Study Location Near You

This study is available at 52 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Hefei, Anhui
  • • Beijing, Beijing Municipality
  • • Lanzhou, Gansu
  • • And 49 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema - Join Clinical Trial NCTNCT06422507

How to Join This Clinical Trial - NCTNCT06422507

Learn how to participate in this PHASE3 trial studying an investigational therapy for Diabetic Macular Edema. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diabetic Macular Edema. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diabetic Macular Edema
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06422507 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 52 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230601 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100730 - China

Status: Contact for availability

Clinical Research Site

Lanzhou, Gansu 730030 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510120 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510180 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510280 - China

Status: Contact for availability

Clinical Research Site

Nanning, Guangxi 530021 - China

Status: Contact for availability

Clinical Research Site

Harbin, Heilongjiang 150001 - China

Status: Contact for availability

Clinical Research Site

Luoyang, Henan 471002 - China

Status: Contact for availability

Clinical Research Site

Wuhan, Hubei 430040 - China

Status: Contact for availability

And 42 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Diabetic Macular Edema:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation